Featured Articles
-
Waiver Of Consent vs Waiver Of Written Consent
11/21/2024
Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.
-
5 Best Practices For Getting Started With ePRO
9/16/2024
Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
9/16/2024
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot
8/19/2024
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
-
An Expert's View On Choosing And Developing An eCOA Strategy
8/19/2024
Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.
-
Do We Still Need Patients In Tomorrow's Trials?
8/19/2024
Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.
-
DTx Company Leverages Real-World Evidence Platform In Registry Study
8/19/2024
Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.
-
Navigating The Evolving Regulatory And Data Landscape
8/19/2024
Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.
-
5 Key Takeaways From The FDA's Real-World Evidence Guidance
8/19/2024
With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
How Optina Diagnostics Used EDC In Earlier Disease Detection
5/15/2024
Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.